TIMP2 and neoplasm: Present study is the continuation of our previous investigations, where we assessed whether the serum levels of MMP-2 and TIMP-2 might be used as potential tumor markers for gastric (GC), esophageal (EC) and colorectal cancer (CC) [14–16].